SCHEMBL2199129

SCHEMBL2199129

Cn1nc(C(=O)O)cc1-c1ccccc1-c1cc2ccccc2o1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.46
ALDH1A1 P00352 6/20 0.46
TDP1 Q9NUW8 3/20 0.43
MAOB P27338 2/20 0.43
MAOA P21397 1/20 0.43
MEN1 O00255 6/20 0.42
KMT2A Q03164 6/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
POLB P06746 2/20 0.41
MKNK1 Q9BUB5 4/20 0.41
CTDSP1 Q9GZU7 1/20 0.40
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39
PLA2G10 O15496 1/20 0.39
NPC1 O15118 1/20 0.39
NFKB1 P19838 1/20 0.39
NPY1R P25929 1/20 0.39
RAB9A P51151 1/20 0.39
NFKB2 Q00653 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2199127 0.83 MAOB (0.45) KDM4EALDH1A1TDP1MAOBMAOA
SCHEMBL2201625 0.78 KDM4E (0.58) KDM4EALDH1A1TDP1MAOBMAOA
SCHEMBL2197043 0.77 GRIN2B (0.46) KDM4EALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL2199010 0.76 KDM4E (0.45) KDM4EALDH1A1TDP1MAOBMAOA
SCHEMBL1985314 0.76 ALDH1A1 (0.62) KDM4EALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL2202913 0.75 POLR1A (0.42) KDM4EALDH1A1MKNK1HPGDNPC1
SCHEMBL68817 0.74 PLA2G10 (0.49) KDM4EALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL1940302 0.73 KMT2A (0.64) ALDH1A1MEN1KMT2AL3MBTL1POLB
SCHEMBL2209825 0.71 TSHR (0.58) KDM4EALDH1A1TDP1MAOBMAOA
SCHEMBL15862514 0.71 MARS1 (0.47) KDM4EALDH1A1TDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977358-B2 Pyrazol derivatives HOFFMANN-LA ROCHE INC. (US) 2011-07-12 US disclosed
EP-2182953-A2 NEW PYRAZOL DERIVATIVES F. Hoffmann-Roche AG (CH) 2010-05-12 EP disclosed
US-20090029963-A1 PYRAZOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2009-01-29 US disclosed
WO-2009013211-A2 NEW PYRAZOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2009-01-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090029963-A1 PYRAZOL DERIVATIVES CCR1, CCR3, CCRL2 KDM4E 3694/4885ALDH1A1 1476/4885TDP1 3303/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.